1 Nintedanib Market Overview 1.1 Nintedanib Product Overview 1.2 Nintedanib Market Segment by Type 1.2.1 100mg*10 Capsules 1.2.2 150mg*10 Capsules 1.2.3 100mg*30 Capsules 1.2.4 150mg*30 Capsules 1.2.5 150mg*60 Capsules 1.3 Global Nintedanib Market Size by Type 1.3.1 Global Nintedanib Market Size Overview by Type (2016-2027) 1.3.2 Global Nintedanib Historic Market Size Review by Type (2016-2021) 1.3.2.1 Global Nintedanib Sales Breakdown in Volume by Type (2016-2021) 1.3.2.2 Global Nintedanib Sales Breakdown in Value by Type (2016-2021) 1.3.2.3 Global Nintedanib Average Selling Price (ASP) by Type (2016-2021) 1.3.3 Global Nintedanib Forecasted Market Size by Type (2022-2027) 1.3.3.1 Global Nintedanib Sales Breakdown in Volume by Type (2022-2027) 1.3.3.2 Global Nintedanib Sales Breakdown in Value by Type (2022-2027) 1.3.3.3 Global Nintedanib Average Selling Price (ASP) by Type (2022-2027) 1.4 Key Regions Market Size Segment by Type 1.4.1 North America Nintedanib Sales Breakdown by Type (2016-2021) 1.4.2 Europe Nintedanib Sales Breakdown by Type (2016-2021) 1.4.3 Asia-Pacific Nintedanib Sales Breakdown by Type (2016-2021) 1.4.4 Latin America Nintedanib Sales Breakdown by Type (2016-2021) 1.4.5 Middle East and Africa Nintedanib Sales Breakdown by Type (2016-2021) 2 Global Nintedanib Market Competition by Company 2.1 Global Top Players by Nintedanib Sales (2016-2021) 2.2 Global Top Players by Nintedanib Revenue (2016-2021) 2.3 Global Top Players Nintedanib Price (2016-2021) 2.4 Global Top Manufacturers Nintedanib Manufacturing Base Distribution, Sales Area, Product Type 2.5 Nintedanib Market Competitive Situation and Trends 2.5.1 Nintedanib Market Concentration Rate (2016-2021) 2.5.2 Global 5 and 10 Largest Manufacturers by Nintedanib Sales and Revenue in 2020 2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nintedanib as of 2020) 2.7 Date of Key Manufacturers Enter into Nintedanib Market 2.8 Key Manufacturers Nintedanib Product Offered 2.9 Mergers & Acquisitions, Expansion 3 Nintedanib Status and Outlook by Region 3.1 Global Nintedanib Market Size and CAGR by Region: 2016 VS 2021 VS 2026 3.2 Global Nintedanib Historic Market Size by Region 3.2.1 Global Nintedanib Sales in Volume by Region (2016-2021) 3.2.2 Global Nintedanib Sales in Value by Region (2016-2021) 3.2.3 Global Nintedanib Sales (Volume & Value) Price and Gross Margin (2016-2021) 3.3 Global Nintedanib Forecasted Market Size by Region 3.3.1 Global Nintedanib Sales in Volume by Region (2022-2027) 3.3.2 Global Nintedanib Sales in Value by Region (2022-2027) 3.3.3 Global Nintedanib Sales (Volume & Value), Price and Gross Margin (2022-2027) 4 Global Nintedanib by Application 4.1 Nintedanib Market Segment by Application 4.1.1 Locally Advanced NSCLC 4.1.2 Variant NSCLC 4.1.3 Locally Recurrent NSCLC 4.2 Global Nintedanib Market Size by Application 4.2.1 Global Nintedanib Market Size Overview by Application (2016-2027) 4.2.2 Global Nintedanib Historic Market Size Review by Application (2016-2021) 4.2.2.1 Global Nintedanib Sales Breakdown in Volume, by Application (2016-2021) 4.2.2.2 Global Nintedanib Sales Breakdown in Value, by Application (2016-2021) 4.2.2.3 Global Nintedanib Average Selling Price (ASP) by Application (2016-2021) 4.2.3 Global Nintedanib Forecasted Market Size by Application (2022-2027) 4.2.3.1 Global Nintedanib Sales Breakdown in Volume, by Application (2022-2027) 4.2.3.2 Global Nintedanib Sales Breakdown in Value, by Application (2022-2027) 4.2.3.3 Global Nintedanib Average Selling Price (ASP) by Application (2022-2027) 4.3 Key Regions Market Size Segment by Application 4.3.1 North America Nintedanib Sales Breakdown by Application (2016-2021) 4.3.2 Europe Nintedanib Sales Breakdown by Application (2016-2021) 4.3.3 Asia-Pacific Nintedanib Sales Breakdown by Application (2016-2021) 4.3.4 Latin America Nintedanib Sales Breakdown by Application (2016-2021) 4.3.5 Middle East and Africa Nintedanib Sales Breakdown by Application (2016-2021) 5 North America Nintedanib by Country 5.1 North America Nintedanib Historic Market Size by Country 5.1.1 North America Nintedanib Sales in Volume by Country (2016-2021) 5.1.2 North America Nintedanib Sales in Value by Country (2016-2021) 5.2 North America Nintedanib Forecasted Market Size by Country 5.2.1 North America Nintedanib Sales in Volume by Country (2022-2027) 5.2.2 North America Nintedanib Sales in Value by Country (2022-2027) 6 Europe Nintedanib by Country 6.1 Europe Nintedanib Historic Market Size by Country 6.1.1 Europe Nintedanib Sales in Volume by Country (2016-2021) 6.1.2 Europe Nintedanib Sales in Value by Country (2016-2021) 6.2 Europe Nintedanib Forecasted Market Size by Country 6.2.1 Europe Nintedanib Sales in Volume by Country (2022-2027) 6.2.2 Europe Nintedanib Sales in Value by Country (2022-2027) 7 Asia-Pacific Nintedanib by Region 7.1 Asia-Pacific Nintedanib Historic Market Size by Region 7.1.1 Asia-Pacific Nintedanib Sales in Volume by Region (2016-2021) 7.1.2 Asia-Pacific Nintedanib Sales in Value by Region (2016-2021) 7.2 Asia-Pacific Nintedanib Forecasted Market Size by Region 7.2.1 Asia-Pacific Nintedanib Sales in Volume by Region (2022-2027) 7.2.2 Asia-Pacific Nintedanib Sales in Value by Region (2022-2027) 8 Latin America Nintedanib by Country 8.1 Latin America Nintedanib Historic Market Size by Country 8.1.1 Latin America Nintedanib Sales in Volume by Country (2016-2021) 8.1.2 Latin America Nintedanib Sales in Value by Country (2016-2021) 8.2 Latin America Nintedanib Forecasted Market Size by Country 8.2.1 Latin America Nintedanib Sales in Volume by Country (2022-2027) 8.2.2 Latin America Nintedanib Sales in Value by Country (2022-2027) 9 Middle East and Africa Nintedanib by Country 9.1 Middle East and Africa Nintedanib Historic Market Size by Country 9.1.1 Middle East and Africa Nintedanib Sales in Volume by Country (2016-2021) 9.1.2 Middle East and Africa Nintedanib Sales in Value by Country (2016-2021) 9.2 Middle East and Africa Nintedanib Forecasted Market Size by Country 9.2.1 Middle East and Africa Nintedanib Sales in Volume by Country (2022-2027) 9.2.2 Middle East and Africa Nintedanib Sales in Value by Country (2022-2027) 10 Company Profiles and Key Figures in Nintedanib Business 10.1 Boehringer Ingelheim Pharma 10.1.1 Boehringer Ingelheim Pharma Corporation Information 10.1.2 Boehringer Ingelheim Pharma Introduction and Business Overview 10.1.3 Boehringer Ingelheim Pharma Nintedanib Sales, Revenue and Gross Margin (2016-2021) 10.1.4 Boehringer Ingelheim Pharma Nintedanib Products Offered 10.1.5 Boehringer Ingelheim Pharma Recent Development 11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis 11.1 Nintedanib Key Raw Materials 11.1.1 Key Raw Materials 11.1.2 Key Raw Materials Price 11.1.3 Raw Materials Key Suppliers 11.2 Manufacturing Cost Structure 11.2.1 Raw Materials 11.2.2 Labor Cost 11.2.3 Manufacturing Expenses 11.3 Nintedanib Industrial Chain Analysis 11.4 Nintedanib Market Dynamics 11.4.1 Industry Trends 11.4.2 Market Drivers 11.4.3 Market Challenges 11.4.4 Market Restraints 12 Market Strategy Analysis, Distributors 12.1 Sales Channel 12.2 Nintedanib Distributors 12.3 Nintedanib Downstream Customers 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.1.1 Research Programs/Design 14.1.1.2 Market Size Estimation 14.1.1.3 Market Breakdown and Data Triangulation 14.1.2 Data Source 14.1.2.1 Secondary Sources 14.1.2.2 Primary Sources 14.2 Author Details 14.3 Disclaimer

List of Tables Table 1. Major Company of 100mg*10 Capsules Table 2. Major Company of 150mg*10 Capsules Table 3. Major Company of 100mg*30 Capsules Table 4. Major Company of 150mg*30 Capsules Table 5. Major Company of 150mg*60 Capsules Table 6. Global Nintedanib Sales by Type 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Nintedanib Sales by Type (2016-2021) & (K Pcs) Table 8. Global Nintedanib Sales Market Share in Volume by Type (2016-2021) Table 9. Global Nintedanib Sales by Type (2016-2021) & (US& Million) Table 10. Global Nintedanib Market Share in Value by Type (2016-2021) Table 11. Global Nintedanib Price by Type (2016-2021) & (USD/Pcs) Table 12. Global Nintedanib Sales by Type (2022-2027) & (K Pcs) Table 13. Global Nintedanib Sales Market Share in Volume by Type (2022-2027) Table 14. Global Nintedanib Sales by Type (2022-2027) & (US$ Million) Table 15. Global Nintedanib Sales Market Share in Value by Type (2022-2027) Table 16. Global Nintedanib Price by Type (2022-2027) & (USD/Pcs) Table 17. North America Nintedanib Sales by Type (2016-2021) & (K Pcs) Table 18. North America Nintedanib Sales by Type (2016-2021) & (US$ Million) Table 19. Europe Nintedanib Sales (K Pcs) by Type (2016-2021) Table 20. Europe Nintedanib Sales by Type (2016-2021) & (US$ Million) Table 21. Asia-Pacific Nintedanib Sales (K Pcs) by Type (2016-2021) Table 22. Asia-Pacific Nintedanib Sales by Type (2016-2021) & (US$ Million) Table 23. Latin America Nintedanib Sales (K Pcs) by Type (2016-2021) Table 24. Latin America Nintedanib Sales by Type (2016-2021) & (US$ Million) Table 25. Middle East and Africa Nintedanib Sales (K Pcs) by Type (2016-2021) Table 26. Middle East and Africa Nintedanib Sales by Type (2016-2021) & (US$ Million) Table 27. Global Nintedanib Sales by Company (2016-2021) & (K Pcs) Table 28. Global Nintedanib Sales Share by Company (2016-2021) Table 29. Global Nintedanib Revenue by Company (2016-2021) & (US$ Million) Table 30. Global Nintedanib Revenue Share by Company (2016-2021) Table 31. Global Market Nintedanib Price by Company (2016-2021) & (USD/Pcs) Table 32. Global Nintedanib Top Manufacturers Manufacturing Base Distribution and Sales Area Table 33. Global Nintedanib Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Nintedanib as of 2020 Table 35. Date of Key Manufacturers Enter into Nintedanib Market Table 36. Key Manufacturers Nintedanib Product Type Table 37. Mergers & Acquisitions, Expansion Plans Table 38. Global Nintedanib Market Size Comparison by Region (US$ Million): 2016 VS 2021 VS 2027 Table 39. Global Nintedanib Sales by Region (2016-2021) & (K Pcs) Table 40. Global Nintedanib Sales Market Share in Volume by Region (2016-2021) Table 41. Global Nintedanib Sales by Region (2016-2021) & (US$ Million) Table 42. Global Nintedanib Sales Market Share in Value by Region (2016-2021) Table 43. Global Nintedanib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2016-2021) Table 44. Global Nintedanib Sales by Region (2022-2027) & (K Pcs) Table 45. Global Nintedanib Sales Market Share in Volume by Region (2022-2027) Table 46. Global Nintedanib Sales by Region (2022-2027) & (US$ Million) Table 47. Global Nintedanib Sales Market Share in Value by Region (2022-2027) Table 48. Global Nintedanib Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2022-2027) Table 49. Global Nintedanib Sales by Application: 2016 VS 2021 VS 2027 (US$ Million) Table 50. Global Nintedanib Sales by Application (2016-2021) & (K Pcs) Table 51. Global Nintedanib Sales Market Share in Volume by Application (2016-2021) Table 52. Global Nintedanib Sales by Application (2016-2021) & (US$ Million) Table 53. Global Nintedanib Sales Market Share in Value by Application (2016-2021) Table 54. Global Nintedanib Price by Application (2016-2021) & (USD/Pcs) Table 55. Global Nintedanib Sales by Application (2022-2027) & (K Pcs) Table 56. Global Nintedanib Sales Market Share in Volume by Application (2022-2027) Table 57. Global Nintedanib Sales by Application (2022-2027) & (US$ Million) Table 58. Global Nintedanib Sales Market Share in Value by Application (2022-2027) Table 59. Global Nintedanib Price by Application (2022-2027) & (USD/Pcs) Table 60. North America Nintedanib Sales by Application (2016-2021) (K Pcs) Table 61. North America Nintedanib Sales by Application (2016-2021) & (US$ Million) Table 62. North America Nintedanib Sales Market Share in Value by Application in 2020 Table 63. Europe Nintedanib Sales by Application (2016-2021) (K Pcs) Table 64. Europe Nintedanib Sales by Application (2016-2021) & (US$ Million) Table 65. Europe Nintedanib Sales Market Share in Value by Application in 2020 Table 66. Asia-Pacific Nintedanib Sales by Application (2016-2021) (K Pcs) Table 67. Asia-Pacific Nintedanib Sales by Application (2016-2021) & (US$ Million) Table 68. Asia-Pacific Nintedanib Sales Market Share in Value by Application in 2020 Table 69. Latin America Nintedanib Sales by Application (2016-2021) (K Pcs) Table 70. Latin America Nintedanib Sales by Application (2016-2021) & (US$ Million) Table 71. Latin America Nintedanib Sales Market Share in Value by Application in 2020 Table 72. Middle East and Africa Nintedanib Sales by Application (2016-2021) (K Pcs) Table 73. Middle East and Africa Nintedanib Sales by Application (2016-2021) & (US$ Million) Table 74. Middle East and Africa Nintedanib Sales Market Share in Value by Application in 2020 Table 75. North America Nintedanib Sales by Country (2016-2021) & (K Pcs) Table 76. North America Nintedanib Sales Market Share in Volume by Country (2016-2021) Table 77. North America Nintedanib Sales by Country (2016-2021) & (US$ Million) Table 78. North America Nintedanib Sales Market Share in Value by Country (2016-2021) Table 79. North America Nintedanib Sales by Country (2022-2027) & (K Pcs) Table 80. North America Nintedanib Sales Market Share in Volume by Country (2022-2027) Table 81. North America Nintedanib Sales by Country (2022-2027) & (US$ Million) Table 82. North America Nintedanib Sales Market Share in Value by Country (2022-2027) Table 83. Europe Nintedanib Sales by Country (2016-2021) & (K Pcs) Table 84. Europe Nintedanib Sales Market Share in Volume by Country (2016-2021) Table 85. Europe Nintedanib Sales by Country (2016-2021) & (US$ Million) Table 86. Europe Nintedanib Sales Market Share in Value by Country (2016-2021) Table 87. Europe Nintedanib Sales by Country (2022-2027) & (K Pcs) Table 88. Europe Nintedanib Sales Market Share in Volume by Country (2022-2027) Table 89. Europe Nintedanib Sales by Country (2022-2027) & (US$ Million) Table 90. Europe Nintedanib Sales Market Share in Value by Country (2022-2027) Table 91. Asia-Pacific Nintedanib Sales by Region (2016-2021) & (K Pcs) Table 92. Asia-Pacific Nintedanib Sales Market Share in Volume by Region (2016-2021) Table 93. Asia-Pacific Nintedanib Sales by Region (2016-2021) & (US$ Million) Table 94. Asia-Pacific Nintedanib Sales Market Share in Value by Region (2016-2021) Table 95. Asia-Pacific Nintedanib Sales by Region (2022-2027) & (K Pcs) Table 96. Asia-Pacific Nintedanib Sales Market Share in Volume by Region (2022-2027) Table 97. Asia-Pacific Nintedanib Sales by Region (2022-2027) & (US$ Million) Table 98. Asia-Pacific Nintedanib Sales Market Share in Value by Region (2022-2027) Table 99. Latin America Nintedanib Sales by Country (2016-2021) & (K Pcs) Table 100. Latin America Nintedanib Sales Market Share in Volume by Country (2016-2021) Table 101. Latin America Nintedanib Sales by Country (2016-2021) & (US$ Million) Table 102. Latin America Nintedanib Sales Market Share in Value by Country (2016-2021) Table 103. Latin America Nintedanib Sales by Country (2022-2027) & (K Pcs) Table 104. Latin America Nintedanib Sales Market Share in Volume by Country (2022-2027) Table 105. Latin America Nintedanib Sales by Country (2022-2027) & (US$ Million) Table 106. Latin America Nintedanib Sales Market Share in Value by Country (2022-2027) Table 107. Middle East and Africa Nintedanib Sales by Country (2016-2021) & (K Pcs) Table 108. Middle East and Africa Nintedanib Sales Market Share in Volume by Country (2016-2021) Table 109. Middle East and Africa Nintedanib Sales by Country (2016-2021) & (US$ Million) Table 110. Middle East and Africa Nintedanib Sales Market Share in Value by Country (2016-2021) Table 111. Middle East and Africa Nintedanib Sales by Country (2022-2027) & (K Pcs) Table 112. Middle East and Africa Nintedanib Sales Market Share in Volume by Country (2022-2027) Table 113. Middle East and Africa Nintedanib Sales by Country (2022-2027) & (US$ Million) Table 114. Middle East and Africa Nintedanib Sales Market Share in Value by Country (2022-2027) Table 115. Boehringer Ingelheim Pharma Corporation Information Table 116. Boehringer Ingelheim Pharma Introduction and Business Overview Table 117. Boehringer Ingelheim Pharma Nintedanib Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. Boehringer Ingelheim Pharma Nintedanib Product Table 119. Boehringer Ingelheim Pharma Recent Development Table 120. Key Raw Materials Lists Table 121. Raw Materials Key Suppliers Lists Table 122. Nintedanib Market Trends Table 123. Nintedanib Market Drivers Table 124. Nintedanib Market Challenges Table 125. Nintedanib Market Restraints Table 126. Nintedanib Distributors List Table 127. Nintedanib Downstream Customers Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Nintedanib Product Picture Figure 2. Global Nintedanib Market Size, 2016 VS 2021 VS 2027 (US$ Million) Figure 3. Global Nintedanib Market Size Status and Outlook (2016-2027) & (US$ Million) Figure 4. Global Nintedanib Sales Status and Outlook (2016-2027) & (K Pcs) Figure 5. Product Picture of 100mg*10 Capsules Figure 6. Global 100mg*10 Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 7. Product Picture of 150mg*10 Capsules Figure 8. Global 150mg*10 Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 9. Product Picture of 100mg*30 Capsules Figure 10. Global 100mg*30 Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 11. Product Picture of 150mg*30 Capsules Figure 12. Global 150mg*30 Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 13. Product Picture of 150mg*60 Capsules Figure 14. Global 150mg*60 Capsules Sales YoY Growth (2016-2021) & (K Pcs) Figure 15. Global Nintedanib Sales by Type (2016-2027) & (US$ Million) Figure 16. Global Nintedanib Sales Market Share in Volume by Type (2016-2021) Figure 17. Global Nintedanib Sales Market Share in Value by Type (2016-2021) Figure 18. Global Nintedanib Sales Market Share in Volume by Type (2022-2027) Figure 19. Global Nintedanib Sales Market Share in Value by Type (2022-2027) Figure 20. North America Nintedanib Sales Market Share in Volume by Type in 2020 Figure 21. North America Nintedanib Sales Market Share in Value by Type in 2020 Figure 22. Europe Nintedanib Sales Market Share in Volume by Type in 2020 Figure 23. Europe Nintedanib Sales Market Share in Value by Type in 2020 Figure 24. Asia-Pacific Nintedanib Sales Market Share in Volume by Type in 2020 Figure 25. Asia-Pacific Nintedanib Sales Market Share in Value by Type in 2020 Figure 26. Latin America Nintedanib Sales Market Share in Volume by Type in 2020 Figure 27. Latin America Nintedanib Sales Market Share in Value by Type in 2020 Figure 28. Middle East and Africa Nintedanib Sales Market Share in Volume by Type in 2020 Figure 29. Middle East and Africa Nintedanib Sales Market Share in Value by Type in 2020 Figure 30. The 5 and 10 Largest Manufacturers in the World: Market Share by Nintedanib Sales in 2020 Figure 31. The 5 and 10 Largest Manufacturers in the World: Market Share by Nintedanib Revenue in 2020 Figure 32. Nintedanib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Product Picture of Locally Advanced NSCLC Figure 34. Global Locally Advanced NSCLC Sales YoY Growth (2016-2027) & (K Pcs) Figure 35. Product Picture of Variant NSCLC Figure 36. Global Variant NSCLC Sales YoY Growth (2016-2027) & (K Pcs) Figure 37. Product Picture of Locally Recurrent NSCLC Figure 38. Global Locally Recurrent NSCLC Sales YoY Growth (2016-2027) & (K Pcs) Figure 39. Global Nintedanib Sales by Application (2016-2027) & (US$ Million) Figure 40. Global Nintedanib Sales Market Share in Volume by Application (2016-2021) Figure 41. Global Nintedanib Sales Market Share in Value by Application (2016-2021) Figure 42. Global Nintedanib Sales Market Share in Volume by Application (2022-2027) Figure 43. North America Nintedanib Sales Market Share in Volume by Application in 2020 Figure 44. Latin America Nintedanib Sales Market Share in Value by Application in 2020 Figure 45. Middle East and Africa Nintedanib Sales Market Share in Value by Application in 2020 Figure 46. Key Raw Materials Price Figure 47. Nintedanib Manufacturing Cost Structure Figure 48. Nintedanib Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Boehringer Ingelheim Pharma